For the PXA WHO Grade 2 tumors, the Ki-67 labeling index is generally <1%, whereas up to 15% has been reported in their WHO Grade 3 counterparts (3, 13, 21). This evidence concerns the gene MKI67 and pleomorphic xanthoastrocytoma.